IntelliProve’s founders, from left: Brecht Dhuyvetters, Joeri Tulkens, Maxime Mattelin and Tanguy Sanglet.
Belgian healthtech startup IntelliProve has raised €2.7 million in seed funding to take its camera-based health scan from virtual care apps to humanoid robots. Miles Ahead led the round. Home nursing organisation Wit-Gele Kruis, the imec.istart Fund, and several business angels also took part.
The Ghent company’s software reads heart rate, heart rate variability (HRV), breathing, and blood pressure from a 30-second face scan. It needs only a standard camera, and no cuff. Care providers, insurers, and wellbeing platforms in more than 50 countries already build it into their apps, IntelliProve said.
“This funding round allows us to invest in technology and growth. We can open conversations with robotics companies and virtual care partners worldwide, while doubling down on the data and certification that make all of it possible,” co-CEO Joeri Tulkens told TNW. “Our ambition is simple: a health sensing layer that care can rely on, on any camera.”
A third each for regulation, growth, and research
Roughly a third of the money goes to regulatory work and a third to further research, Tulkens told TNW. The last third goes to commercial growth, including robotics deployments.
IntelliProve already holds a CE mark as a Class I medical device under the EU Medical Device Regulation. That mark covers its core signal acquisition engine, the technology that pulls physiological signals from facial video, Tulkens said. The company is now working towards Class IIa certification, but would not say yet which measurements that will cover.
The scan on IntelliProve’s website is a lighter version for developers to test. It returns heart rate, HRV, and respiratory rate. Blood pressure is available to integration partners, Tulkens said.
How the scan works
The technique is called remote photoplethysmography, or rPPG. Each heartbeat changes the colour of facial skin very slightly, and a camera can pick up the change. IntelliProve’s software tracks the skin as the person moves, extracts the pulse signal, and estimates blood pressure from the shape of the pulse wave with an in-house deep learning model.
The company says its models are validated on more than 6 million data points. In its own tests, 97.6% of heart rate readings fell within five beats per minute of a reference device, its press kit says.
IntelliProve works with TU Delft, Ghent University Hospital, and Wit-Gele Kruis, which is also an investor.
From phones to robots
The company wants the same layer in humanoid robots heading into homes and care facilities. Investors are backing robot makers, from Agile Robots’ $500M round to Minerva Humanoids’ pre-seed. A robot would offer the scan with the cameras it already has. It would then pass the values to a person, who decides what happens next.
IntelliProve said it already works with selected robotics partners. It did not name them when TNW asked. The funding will also pay for more data across skin tones, ages, lighting, and devices. It also covers certification beyond Europe.
“Whether the scan runs on a smartphone or on a humanoid robot, the bar stays the same,” co-founder and CTO Tanguy Sanglet said in a statement.
Get the TNW newsletter
Get the most important tech news in your inbox each week.